PubAg

Main content area

Kefir reduces the incidence of pre-neoplastic lesions in an animal model for colorectal cancer

Author:
dos Reis, Sandra Aparecida, da Conceição, Lisiane Lopes, e Dias, Mariana Moura, Siqueira, Nathane Paes, Rosa, Damiana Diniz, de Oliveira, Leandro Licursi, da Matta, Sérgio Luis Pinto, Peluzio, Maria do Carmo Gouveia
Source:
Journal of functional foods 2019 v.53 pp. 1-6
ISSN:
1756-4646
Subject:
animal models, antioxidant activity, catalase, colorectal neoplasms, immunomodulation, interleukin-1beta, intestines, kefir, laboratory animals, lactulose, mannitol, milk, permeability, rats, short chain fatty acids, tumor necrosis factor-alpha
Abstract:
This study aimed to evaluate the effect of regular consumption of milk kefir on the development of pre-neoplastic colonic lesions. Thirty Wistar rats received water (Control group) or milk (Milk group) or kefir (Kefir group) during five weeks. After that, colonic lesions were chemically induced and the treatments continued for more thirteen weeks. The regular consumption of kefir was able to reduce the incidence of aberrant crypt foci by 36%. Also, the consumption of kefir increased the cecal concentration of short chain fatty acids; reduced the lactulose/mannitol ratio; promoted an increase in the colonic concentration of TNF-α and IL-1β, and the enzyme catalase in comparison with the control group. Thus, kefir reduced the development of lesions, probably by increasing the production of short chain fatty acids; reduction of intestinal permeability; immunomodulation and improvement of colonic antioxidant activity.
Agid:
6252729